Oxford VR gets £3.2m to bring clinically validated tech to market

Oxford VR, a health-focused startup spinout from the University of Oxford, has managed to raise £3.2m in investment from investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Oxford VR launched their first product this year, an automated VR treatment to help people with acrophobia, and ran a large, randomised test which was so successful it is now being used in select NHS clinics. 

They will use the funding to grow and bring automated immersive, clinically validated VR technologies to market.

Oxford VR is hoping to help millions of people with their VR technology that is more accessible, faster, cheaper and effective than traditional treatments.

To read more, click here.